ROCKVILLE, Md., Jan. 01, 2024 (GLOBE NEWSWIRE) MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and
Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel,.
MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicinesROCKVILLE, Md., Nov. 16, 2023 MaxCyte, Inc., , a leading,.
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.